Blink Device Company Launches TwitchView™ Neuromuscular TOF Monitor at American Society of Anesthesia Meeting

Presents Clinical Validation Data Establishing Equivalence to Gold Standard

SEATTLE, WA October 10, 2018 - Blink Device Company announced today that it is formally launching TwitchView™, a new quantitative train-of-four monitor for neuromuscular blockade, at the American Society of Anesthesia’s annual conference in San Francisco.  

Professor Andrew Bowdle will present results from a study conducted at the University of Washington comparing the TwitchView’s EMG algorithm to acceleromyography and “gold standard” mechanomyography. Dr. Bowdle stated, “The EMG was highly correlated to mechanomyography.  We were also able to tuck the arm and obtain excellent results, which is not possible with acceleromyography.”     

“We’ve had an overwhelmingly positive response during our pilot launch.” said CEO Justin Hulvershorn, M.D, Ph.D.  “Based on our initial experience, TwitchView changes the way clinicians approach the management of neuromuscular block, including a more informed, rationale, and cost-effective approach to drug usage.  We strongly believe this next generation technology significantly improves patient care and will rapidly find its way into operating rooms all over the world.”